Reporting directly to the Japan Head of Real-World Evidence & Health Outcomes, the role will:
• Shape evidence-generation strategy across therapeutic areas and drive cross-portfolio operational synergies.
• Acts as leader to enterprise evidence strategy and operations, covering aspects of evidence synthesis,
analytics and study operations to provide coaching and implement internal standards and processes.
• Responsible for the timing and quality delivery of the study/ projects and organize the regular study
monitor meeting for dashboard management.
• Ensures study quality standards, i.e. no significant compliance (GCP, SOP or applicable regulations)
issue throughout study planning and execution.
• Redefine processes and ways of working to enable more efficient and effective planning and execution
of data-generation programs, standardizing workflows, reducing duplication and accelerating delivery
• Responsible for the quality of outsource service through vendor management.
• Maintains effective communication with internal and external stakeholders.
• Proactively identify and drive cross-TA and cross-portfolio synergies (e.g., data reuse, harmonized study
designs, shared analytics) to increase efficiency, reduce duplication and accelerate timelines.
• Represents Japan RWE-HO in cross-regional forums on evidence strategy, ensuring alignment with
global RWE-HO initiatives and facilitating two-way knowledge transfer.
• Partners closely with Global RWE-HO to prepare QBRs and townhalls, and to promote best-practice
sharing in Japan and across other regions.